Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Myeloid Malignancies × magrolimab × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Squamous Cell Carcinoma of Head and Neck 2 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Myeloid Malignancies 1 Multiple Myeloma 1 Lymphoma, B-Cell 1 Leukemia, Myeloid, Acute 1 Hodgkin Disease 1 Colorectal Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

venetoclax 1 olutasidenib 1 magrolimab 1 cc-486 1 Mitoxantrone 1 Etoposide 1 Cytarabine 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04778410 2025-03-20

Study of Magrolimab Combinations in Participants With Myeloid Malignancies

Gilead Sciences

Phase 2 Terminated

54 enrolled 26 charts

Myeloid Malignancies

Data powered by HemOnc (CC BY 4.0) Colophon ⚡